Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 7, 2014 - Issue
Submit an article Journal homepage
167
Views
7
CrossRef citations to date
0
Altmetric
Review

Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach

Antonio Ceriello1 Department of Endocrinology, Hospital Clinic de Barcelona, Institut d’Investigacions Biomèdiques August Pi iSunyer, Barcelona, Spain;2 Centro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metabolicas Asociadas, Barcelona, SpainCorrespondence[email protected]
,
Marco Gallo3 Oncological Endocrinology, AOU Città della Salute e della Scienza-Molinette, Turin, Italy
,
Riccardo Candido4 Diabetes Center, ASS 1 Triestina, Trieste, Italy
,
Alberto De Micheli5 Ligurian Health Agency, Genoa, Italy
,
Katherine Esposito6 Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy
,
Sandro Gentile6 Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy
&
Gerardo Medea7 Italian College of General Practitioners, Florence, Italy
 show all
Pages 129-136 | Published online: 19 Jun 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Varun Kumar Vijayakumar, Tehmina Mustafa, Bjarte Kjell Nore, Kjell Yngvard Garatun-Tjeldstø, Øystein Næss, Odd Erik Johansen & Bernt Bøgvald Aarli. (2021) Role of a Digital Clinical Decision–Support System in General Practitioners’ Management of COPD in Norway. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2327-2336.
Read now

Articles from other publishers (6)

Amartya Mukhopadhyay, Jennifer Sumner, Lieng Hsi Ling, Raphael Hao Chong Quek, Andre Teck Huat Tan, Gim Gee Teng, Santhosh Kumar Seetharaman, Satya Pavan Kumar Gollamudi, Dean Ho & Mehul Motani. (2022) Personalised Dosing Using the CURATE.AI Algorithm: Protocol for a Feasibility Study in Patients with Hypertension and Type II Diabetes Mellitus. International Journal of Environmental Research and Public Health 19:15, pages 8979.
Crossref
Anthony A. Fryer, David Holland, Michael Stedman, Christopher J. Duff, Lewis Green, Jonathan Scargill, Fahmy W. F. Hanna, Pensée Wu, R. John Pemberton, Christine Bloor & Adrian H. Heald. (2022) Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time. Journal of Diabetes Research 2022, pages 1-11.
Crossref
Sin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, Sung Wan Chun, Kyong Soo Park, Kyung Mook Choi, Soo Lim, Ji‐Oh Mok, Hyoung Woo Lee, Ji A. Seo, Bong‐Soo Cha, Mi Kyung Kim, Ho Sang Shon, Dong Seop Choi & Doo Man Kim. (2020) Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks. Diabetes, Obesity and Metabolism 22:10, pages 1869-1873.
Crossref
Joel Rodriguez-Saldana. 2019. The Diabetes Textbook. The Diabetes Textbook 333 355 .
Eberhard Standl, Oliver Schnell, Darren K McGuire, Antonio Ceriello & Lars Rydén. (2017) Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes. The Lancet Diabetes & Endocrinology 5:5, pages 391-402.
Crossref
Swapnil N. Rajpathak, Chunmay Fu, Kimberley Brodovicz, Samuel S. Engel & Pamela C. Heaton. (2015) Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes. Diabetes Research and Clinical Practice 109:3, pages 507-512.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.